That does not mean they should not be following up with the recent information and a possible track to a new improved potential that has just had a PR on the potential improvement. We should explore all avenues for new drugs when one gets a PR like this on bad disease like this.
Might not work, but one should find out if there is a possibility that it might work with MNTA. Stay ahead of the curve.
Yes they are working on it, but I have not seen a PR like this before.